The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Poor response inhibition: At the nexus between substance abuse and attention deficit/hyperactivity disorder
Open accessAbstract
The comorbidity between attention deficit hyperactivity disorder (ADHD) and substance abuse and dependence disorders may have multiple causes and consequences. In this review, we will describe neurobehavioral, genetic and animal model studies that support the notion that a common, genetically-determined failure of response inhibition function is an endophenotype for both disorders. Through an impairment in the ability to cognitively control pre-potent behaviors, subjects can exhibit a collection of ADHD-like traits (impulsivity and hyperactivity), as well as susceptibility for the initiation of drug-taking and its ultimate progression to an inflexible, uncontrollable form. At the neural level, dysfunction within circuitry that includes the ventrolateral frontal and cingulate cortices, as well as in associated basal ganglia zones, contributes to a common pattern of behavioral impairment, explaining aspects of comorbidity. Animal models of substance abuse/dependence and ADHD that exhibit deficits in response inhibition have substantiated the role of this endophenotype in both disorders and their co-morbidity and should provide a testing ground for interventions targeting it. New directions for research that will further explore this hypothesis and begin to reveal the underlying biological mechanisms will be proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 1×
“…(poor working memory, executive function impairments) are common in ADHD patients and may represent key indicators of genetic liability to ADHD (Aron and Poldrack 2005; Barkley 1997; Castellanos and Tannock 2002; Doyle et al. 2005; Nigg et al. 2004), although they are not diagnostic features.”
BackgroundJentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 4×
“…some descriptive theories describe substance abuse/dependence disorders as resulting from drug-induced dysregulation of systems involved in reward and motivation (Koob and Le Moal 1997; Berridge and Robinson 2000) and executive control over reward-related behavior (Jentsch and Taylor 1999).”
BackgroundSelf-citationRobinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement
Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S. J., Theobald, D. E. H., Lääne, K., Peña, Y., Murphy, E. R., Shah, Y., Probst, K., et al. (2007) · Science · doi:10.1126/science.1137073 · Cited by 1,188
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
A developmental functional MRI study of prefrontal activation during performance of a go-no-go task
Casey, B. J., Trainor, R. J., Orendi, J. L., Schubert, A. B., Nystrom, L. E., Giedd, J. N., Castellanos, F. X., Haxby, J. V., Noll, D. C., Cohen, J. D., et al. (1997) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1997.9.6.835 · Cited by 1,106
sagvolden, T., johansen, E. B., aase, H., & russell, V. A. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000075 · Cited by 1,035
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · cited 2×
“DAT KOs exhibit hyperactivity, especially in response to a novel environment, and this hyperactivity is reduced by systemic administration of stimulant drugs (Gainetdinov et al. 1999), paralleling their effects in ADHD patients.”
BackgroundHester, R., & Garavan, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3321-04.2004 · Cited by 657
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617
Aron, A. R., & Poldrack, R. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.026 · Cited by 602
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580
Impaired inhibitory control of behavior in chronic cocaine users
Fillmore, M. T., & Rush, C. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00206-x · Cited by 519
Gill, M., Daly, G., Heron, S., Hawi, Z., & Fitzgerald, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000290 · Cited by 482
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys
Nader, M. A., Morgan, D., Gage, H. D., Nader, S. H., Calhoun, T. L., Buchheimer, N., Ehrenkaufer, R., & Mach, R. H. (2006) · Nature Neuroscience · doi:10.1038/nn1737 · Cited by 481 · cited 1×
“For example, it is known that drug-dependent individuals show lower D2 availability (Volkow et al. 2001), and cocaine self-administration in non-human primates decreases D2 receptor availability (Nader et al. 2006).”
BackgroundVariables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Volkow, N. D., & Swanson, J. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1909 · Cited by 475 · cited 1×
“Finally, ADHD is often effectively treated with the very drugs that support addictive behavior (e.g., stimulants), albeit at doses and via routes of administration that do not typically produce the required brain levels of the drug that support reward and abuse (Volkow and Swanson 2003).”
BackgroundStimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473 · cited 2×
“…show an increase in norepinephrine release in the prefrontal cortex that depends upon autoreceptor sub-sensitivity (Russell et al. 2000; Russell and Wiggins 2000); alterations in prefrontal cortical noradrenergic tone have been implicated in the cognitive control deficits in ADHD (Arnsten 2006a).”
BackgroundDeficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 5×
“Moreover, genetic variation in the gene encoding the dopamine transporter may play a role in the hyperactive and impulsive behavior of SHR rats (Mill et al. 2005), an effect notable due to the fact that variation in the dopamine transporter gene associates with ADHD in humans (Faraone et al. 2005).”
BackgroundInfluentialDiergaarde, L., Pattij, T., Poortvliet, I., Hogenboom, F., de Vries, W., Schoffelmeer, A. N. M., & De Vries, T. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.011 · Cited by 391
Perry, J. L., Larson, E. B., German, J. P., Madden, G. J., & Carroll, M. E. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1994-4 · Cited by 388 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript cocaine than their low impulsivity counterparts (Perry et al. 2005; Poulos et al. 1995).”
BackgroundRobinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288 · cited 2×
“Additionally, methylphenidate and atomoxetine lessen deficits of inhibitory control in ADHD when given at therapeutically effective doses (Aron et al. 2003; Chamberlain et al. 2007; Scheres et al. 2003; Tannock et al. 1989).”
BackgroundHeinz, A., Siessmeier, T., Wrase, J., Buchholz, H. G., Gründer, G., Kumakura, Y., Cumming, P., Schreckenberger, M., Smolka, M. N., Rösch, F., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1515 · Cited by 285
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091465 · Cited by 263 · cited 1×
“These results are seemingly congruent with recent prospective studies indicating that early methylphenidate treatment in ADHD does not increase, and may actually decrease, risk for substance use disorders (Biederman et al. 2008; Mannuzza et al. 2008).”
ResultAltered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259 · cited 1×
“Pre-clinical studies have suggested that developmentally-early treatment with stimulant medications used to treat ADHD reduce sensitivity to addictive drugs in adulthood (Andersen et al. 2002; Mague et al. 2005), but see also (Brandon et al. 2003).”
BackgroundBiederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091486 · Cited by 239 · cited 1×
“These results are seemingly congruent with recent prospective studies indicating that early methylphenidate treatment in ADHD does not increase, and may actually decrease, risk for substance use disorders (Biederman et al. 2008; Mannuzza et al. 2008).”
ResultImpulsivity predicts individual susceptibility to high levels of alcohol self-administration
Poulos, C. X., Le, A. D., & Parker, J. L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199512000-00006 · Cited by 234 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript cocaine than their low impulsivity counterparts (Perry et al. 2005; Poulos et al. 1995).”
BackgroundCornish, K. M., Manly, T., Savage, R., Swanson, J., Morisano, D., Butler, N., Grant, C., Cross, G., Bentley, L., & Hollis, C. P. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001641 · Cited by 220 · cited 2×
“Notably, because a significant association between the DAT1 risk genotype and response inhibition remains after controlling for degree of ADHD symptoms (Cornish et al. 2005), the proximal effect of the risk genotype may lie at the level of response inhibition, not disorder severity.”
BackgroundEffects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats
Richards, J. B., Sabol, K. E., & de Wit, H. (1999) · Psychopharmacology · doi:10.1007/pl00005488 · Cited by 203
Eagle, D. M., Tufft, M. R. A., Goodchild, H. L., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0701-7 · Cited by 176
The Effect of Methylphenidate on Three Forms of Response Inhibition in Boys with AD/HD
Scheres, A., Oosterlaan, J., Swanson, J., Morein-Zamir, S., Meiran, N., Schut, H., Vlasveld, L., & Sergeant, J. A. (2003) · Journal of Abnormal Child Psychology · doi:10.1023/a:1021729501230 · Cited by 176
Effects of acute and chronic nicotine on impulsive choice in rats
Dallery, J., & Locey, M. L. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200502000-00002 · Cited by 113
Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons
Brandon, C. L., Marinelli, M., & White, F. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00787-x · Cited by 107 · cited 1×
“Pre-clinical studies have suggested that developmentally-early treatment with stimulant medications used to treat ADHD reduce sensitivity to addictive drugs in adulthood (Andersen et al. 2002; Mague et al. 2005), but see also (Brandon et al. 2003).”
BackgroundLudolph, A. G., Kassubek, J., Schmeck, K., Glaser, C., Wunderlich, A., Buck, A. K., Reske, S. N., Fegert, J. M., & Mottaghy, F. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.025 · Cited by 83 · cited 1×
“Molecular imaging studies have demonstrated that both ADHD and substance-dependent individuals have altered dopaminergic function and production, particularly in striatal regions (Ernst et al. 1998; Heinz et al. 2005; Ludolph et al. 2008; Martinez et al. 2007).”
BackgroundHIRONAKA, N., IKEDA, K., SORA, I., UHL, G. R., & NIKI, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.018 · Cited by 55 · cited 1×
“Deficits in response inhibition in DAT KOs are evident in the persistent responding observed during extinction of food-reinforced operant responses (Hironaka et al. 2004), as well as in increased perseverative responding to previously-visited arms in a win-shift task (Gainetdinov et al. 1999).”
BackgroundSequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains
Mill, J., Sagvolden, T., & Asherson, P. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-24 · Cited by 49
Cited by
Andreassen, C. S., Billieux, J., Griffiths, M. D., Kuss, D. J., Demetrovics, Z., Mazzoni, E., & Pallesen, S. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000160 · Cited by 2,095
Billieux, J., Maurage, P., Lopez-Fernandez, O., Kuss, D. J., & Griffiths, M. D. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0054-y · Cited by 1,205
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
Models of response inhibition in the stop-signal and stop-change paradigms
Verbruggen, F., & Logan, G. D. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.014 · Cited by 724
Jones, A., Di Lemma, L. C. G., Robinson, E., Christiansen, P., Nolan, S., Tudur-Smith, C., & Field, M. (2016) · Appetite · doi:10.1016/j.appet.2015.11.013 · Cited by 334
Metadata
- Authors
- Groman, S. M., James, A. S., & Jentsch, J. D.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 33
- Issue
- 5
- Pages
- 690-698
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2007980242
- Cited by
- 177
- References
- 43
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.